Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1376125 | Bioorganic & Medicinal Chemistry Letters | 2008 | 4 Pages |
Abstract
The synthesis and SAR of a series of chiral heterocyclic ring-constrained norepinephrine reuptake inhibitors are described. The best compounds compare favorably with atomoxetine in potency (IC50s < 10 nM), selectivity against the other monoamine transporters, and inhibition of CYP2D6 (IC50s > 1 μM). In addition, the compounds are generally more stable than atomoxetine to oxidative metabolism and thus are likely to have lower clearance in humans.
Graphical abstractA series of chiral ring-constrained norepinephrine reuptake inhibitors equivalent to atomoxetine in potency, selectivity, and inhibition of CYP2D6 but more stable to oxidative metabolism.Figure optionsDownload full-size imageDownload as PowerPoint slide
Keywords
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Sarah Hudson, Mehrak Kiankarimi, Wendy Eccles, Wesley Dwight, Yalda S. Mostofi, Marc J. Genicot, Beth A. Fleck, Kathleen Gogas, Anna Aparicio, Hua Wang, Jenny Wen, Warren S. Wade,